Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques
AbstractDrug nanocrystals are nanosized solid drug particles, the most important application of which is the improvement of solubility properties of poorly soluble drug materials. Drug nanocrystals can be produced by many different techniques, but the mostly used are different kinds of media milling techniques; in milling, particle size of bulk sized drug material is decreased, with the aid of milling beads, to nanometer scale. Utilization of Quality by Design, QbD, approach in nanomilling improves the process-understanding of the system, and recently, the number of studies using the QbD approach in nanomilling has increased. In the QbD approach, the quality is built into the products and processes throughout the whole production chain. Definition of Critical Quality Attributes, CQAs, determines the targeted final product properties. CQAs are confirmed by setting Critical Process Parameters, CPPs, which include both process parameters but also input variables, like stabilizer amount or the solid state form of the drug. Finally, Design Space determines the limits in which CPPs should be in order to reach CQAs. This review discusses the milling process and process variables, CPPs, their impact on product properties, CQAs and challenges of the QbD approach in nanomilling studies. View Full-Text
Share & Cite This Article
Peltonen, L. Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques. Pharmaceutics 2018, 10, 104.
Peltonen L. Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques. Pharmaceutics. 2018; 10(3):104.Chicago/Turabian Style
Peltonen, Leena. 2018. "Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques." Pharmaceutics 10, no. 3: 104.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.